• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病合并冠状动脉疾病患者高密度脂蛋白功能与冠状动脉斑块特征的关联:背向散射血管内超声分析

Associations of High-Density Lipoprotein Functionality with Coronary Plaque Characteristics in Diabetic Patients with Coronary Artery Disease: Integrated Backscatter Intravascular Ultrasound Analysis.

作者信息

Takata Kohei, Imaizumi Satoshi, Iwata Atsushi, Zhang Bo, Kawachi Emi, Miura Shin-Ichiro, Ogawa Masahiro

机构信息

Department of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0180, Japan.

Department of Clinical Laboratory and Transfusion, Fukuoka University Hospital, Fukuoka 814-0180, Japan.

出版信息

Biomolecules. 2023 Aug 22;13(9):1278. doi: 10.3390/biom13091278.

DOI:10.3390/biom13091278
PMID:37759677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10526738/
Abstract

High-density lipoprotein (HDL) functionality has been reported to be associated with coronary artery disease (CAD). However, little is known about the impact of HDL functionality on coronary atherosclerosis. Thirty-eight type 2 diabetic patients with CAD who underwent percutaneous coronary intervention were examined. Coronary atheroma burden and plaque composition of the culprit lesions were assessed using conventional gray-scale and integrated backscatter intravascular ultrasound. HDL-mediated cholesterol efflux capacity (HDL-CEC) and HDL antioxidant capacity, estimated as HDL inflammatory index (HII), were examined. The associations between HDL functionality and coronary plaques were analyzed using multivariate data analysis, including principal components analysis and orthogonal partial least squares (OPLS) models. Percent atheroma volume was correlated with HDL-CEC (r = 0.34, = 0.04) but not with HII ( = 0.65). The OPLS model demonstrated that the percentage lipid volume was significantly associated with HDL functionality [coefficient (95% confidence interval); HDL-CEC: -0.26 (-0.49, -0.04); HII: 0.34 (0.08, 2.60), respectively]. HII exhibited the highest variable importance in projection score, indicating the greatest contribution. HDL functionality was associated with coronary plaque composition, a key component of plaque vulnerability. Our findings highlight the potential importance of HDL functionality for coronary plaque stabilization.

摘要

据报道,高密度脂蛋白(HDL)功能与冠状动脉疾病(CAD)有关。然而,关于HDL功能对冠状动脉粥样硬化的影响却知之甚少。对38例接受经皮冠状动脉介入治疗的2型糖尿病CAD患者进行了检查。使用传统的灰阶和背向散射积分血管内超声评估罪犯病变的冠状动脉粥样斑块负荷和斑块成分。检测了HDL介导的胆固醇流出能力(HDL-CEC)和HDL抗氧化能力,以HDL炎症指数(HII)估算。使用多变量数据分析,包括主成分分析和正交偏最小二乘法(OPLS)模型,分析HDL功能与冠状动脉斑块之间的关联。粥样斑块体积百分比与HDL-CEC相关(r = 0.34,P = 0.04),但与HII无关(P = 0.65)。OPLS模型表明,脂质体积百分比与HDL功能显著相关[系数(95%置信区间);HDL-CEC:-0.26(-0.49,-0.04);HII:0.34(0.08,2.60)]。HII在投影得分中表现出最高的变量重要性,表明其贡献最大。HDL功能与冠状动脉斑块成分有关,而斑块成分是斑块易损性的关键组成部分。我们的研究结果突出了HDL功能对冠状动脉斑块稳定的潜在重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/878f3e6ead30/biomolecules-13-01278-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/060c4907b966/biomolecules-13-01278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/0cdaac41a162/biomolecules-13-01278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/44cf03670e26/biomolecules-13-01278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/9ccdcdf76dbd/biomolecules-13-01278-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/878f3e6ead30/biomolecules-13-01278-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/060c4907b966/biomolecules-13-01278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/0cdaac41a162/biomolecules-13-01278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/44cf03670e26/biomolecules-13-01278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/9ccdcdf76dbd/biomolecules-13-01278-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289c/10526738/878f3e6ead30/biomolecules-13-01278-g005.jpg

相似文献

1
Associations of High-Density Lipoprotein Functionality with Coronary Plaque Characteristics in Diabetic Patients with Coronary Artery Disease: Integrated Backscatter Intravascular Ultrasound Analysis.糖尿病合并冠状动脉疾病患者高密度脂蛋白功能与冠状动脉斑块特征的关联:背向散射血管内超声分析
Biomolecules. 2023 Aug 22;13(9):1278. doi: 10.3390/biom13091278.
2
Impact of visit-to-visit variability in blood pressure on coronary plaque as assessed by integrated backscatter intravascular ultrasound.血压变异性对冠状动脉斑块的影响评估:基于背向散射积分的血管内超声研究。
Clin Exp Hypertens. 2020 Oct 2;42(7):608-613. doi: 10.1080/10641963.2020.1756315. Epub 2020 Apr 21.
3
Association of non-HDL cholesterol with plaque burden and composition of culprit lesion in acute coronary syndrome. An intravascular ultrasound-virtual histology study.非高密度脂蛋白胆固醇与急性冠状动脉综合征罪犯病变斑块负荷及成分的关系:血管内超声-虚拟组织学研究。
Indian Heart J. 2024 Sep-Oct;76(5):342-348. doi: 10.1016/j.ihj.2024.10.004. Epub 2024 Oct 9.
4
Effects of sitagliptin on coronary atherosclerosis in patients with type 2 diabetes-A serial integrated backscatter-intravascular ultrasound study.西他列汀对2型糖尿病患者冠状动脉粥样硬化的影响——一项连续集成背向散射-血管内超声研究
Am J Cardiovasc Dis. 2016 Nov 30;6(4):153-162. eCollection 2016.
5
Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study.降低三酰甘油/高密度脂蛋白胆固醇比值与吡格列酮对糖尿病患者冠状动脉粥样硬化进展的有益影响有关:来自 PERISCOPE(吡格列酮对血管内超声冠状动脉阻塞消退的影响前瞻性评估)研究的见解。
J Am Coll Cardiol. 2011 Jan 11;57(2):153-9. doi: 10.1016/j.jacc.2010.06.055.
6
Sex Differences in the Density of Lipidic Plaque Materials: Insights From the REASSURE-NIRS MultiCenter Registry.脂质斑块物质密度的性别差异:来自 REASSURE-NIRS 多中心注册研究的见解。
Circ Cardiovasc Imaging. 2023 May;16(5):e015107. doi: 10.1161/CIRCIMAGING.122.015107. Epub 2023 May 10.
7
High-density lipoprotein cholesterol associated with change in coronary plaque lipid burden assessed by near infrared spectroscopy.高密度脂蛋白胆固醇与近红外光谱评估的冠状动脉斑块脂质负担变化相关。
Atherosclerosis. 2017 Oct;265:110-116. doi: 10.1016/j.atherosclerosis.2017.08.016. Epub 2017 Aug 31.
8
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.他汀类药物、高密度脂蛋白胆固醇与冠状动脉粥样硬化的消退
JAMA. 2007 Feb 7;297(5):499-508. doi: 10.1001/jama.297.5.499.
9
Associations of ABCG1-mediated cholesterol efflux capacity with coronary artery lipid content assessed by near-infrared spectroscopy.通过近红外光谱法评估ABCG1介导的胆固醇流出能力与冠状动脉脂质含量的相关性。
Cardiovasc Diagn Ther. 2019 Aug;9(4):310-318. doi: 10.21037/cdt.2018.11.04.
10
Impact of the low- to high-density lipoprotein cholesterol ratio on composition of angiographically ambiguous left main coronary artery plaque.低-高密度脂蛋白胆固醇比值对血管造影不确定左主干冠状动脉斑块成分的影响。
Circ J. 2011;75(8):1960-7. doi: 10.1253/circj.cj-11-0019. Epub 2011 Jun 4.

引用本文的文献

1
Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes.高密度脂蛋白在1型和2型糖尿病中的抗氧化及抗炎功能
Antioxidants (Basel). 2023 Dec 28;13(1):57. doi: 10.3390/antiox13010057.

本文引用的文献

1
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.贝匹地酸在他汀类药物不耐受患者中的心血管结局。
N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4.
2
Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia.新型ACLY抑制剂326E作为高胆固醇血症的一种有前景的治疗方法的研发。
Acta Pharm Sin B. 2023 Feb;13(2):739-753. doi: 10.1016/j.apsb.2022.06.011. Epub 2022 Jun 18.
3
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.
载脂蛋白 A-I 减少缺血性综合征事件研究 II(AEGIS-II)的原理和设计:一项 3 期、多中心、双盲、随机、安慰剂对照、平行组研究,旨在评估 CSL112 在急性心肌梗死后患者中的疗效和安全性。
Am Heart J. 2021 Jan;231:121-127. doi: 10.1016/j.ahj.2020.10.052. Epub 2020 Oct 13.
4
MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis.微小RNA作为动脉粥样硬化的治疗靶点和临床生物标志物
J Clin Med. 2019 Dec 13;8(12):2199. doi: 10.3390/jcm8122199.
5
Tackling Residual Atherosclerotic Risk in Statin-Treated Adults: Focus on Emerging Drugs.解决他汀类药物治疗成人的残余动脉粥样硬化风险:关注新兴药物。
Am J Cardiovasc Drugs. 2019 Apr;19(2):113-131. doi: 10.1007/s40256-018-0312-1.
6
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial.MILANO-PILOT 试验:富含重组载脂蛋白 A-I 米兰变体的高密度脂蛋白类似物对急性冠脉综合征患者冠心病的影响:一项随机临床试验。
JAMA Cardiol. 2018 Sep 1;3(9):806-814. doi: 10.1001/jamacardio.2018.2112.
7
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial.CER-001 动脉粥样硬化消退急性冠脉综合征试验中 CER-001,一种前β高密度脂蛋白类似物,对急性冠脉综合征后患者冠状动脉粥样硬化的连续输注的影响:一项随机临床试验。
JAMA Cardiol. 2018 Sep 1;3(9):815-822. doi: 10.1001/jamacardio.2018.2121.
8
Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study.经强化他汀类药物治疗后的冠状动脉内影像学、胆固醇流出和转录组学:YELLOW II 研究。
J Am Coll Cardiol. 2017 Feb 14;69(6):628-640. doi: 10.1016/j.jacc.2016.10.029. Epub 2016 Oct 29.
9
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).急性心肌梗死后重组、可输注的血浆源性载脂蛋白A-I(CSL112)的安全性和耐受性:AEGIS-I试验(缺血综合征中载脂蛋白A-I事件减少I)
Circulation. 2016 Dec 13;134(24):1918-1930. doi: 10.1161/CIRCULATIONAHA.116.025687. Epub 2016 Nov 15.
10
Sex Differences in Nonculprit Coronary Plaque Microstructures on Frequency-Domain Optical Coherence Tomography in Acute Coronary Syndromes and Stable Coronary Artery Disease.急性冠状动脉综合征和稳定型冠状动脉疾病中基于频域光学相干断层扫描的非罪犯冠状动脉斑块微结构的性别差异
Circ Cardiovasc Imaging. 2016 Aug;9(8). doi: 10.1161/CIRCIMAGING.116.004506.